JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB33889

Anti-p53 (phospho S392) antibody [EP155Y]

  • RabMAb
  • Lab Essentials
  • 20ul selling size
  • Recombinant
  • What is this?

3

(1 Review)

|

(39 Publications)

Rabbit Recombinant Monoclonal P53 phospho S392 antibody. Suitable for IP, Dot, WB, IHC-P and reacts with Human, Mouse, Rat, Synthetic peptide samples. Cited in 39 publications.

View Alternative Names

P53, TP53, Cellular tumor antigen p53, Antigen NY-CO-13, Phosphoprotein p53, Tumor suppressor p53

11 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human lung carcinoma tissue sections labeling p53 with Purified ab33889 at 1 : 250 dilution. Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

Unpurified ab33889 at a 1/100 dilution staining p53 in paraffin embedded human prostate adenocarcinoma tissue by Immunohistochemistry.

Immunoprecipitation - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • IP

Lab

Immunoprecipitation - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

ab33889 (purified) at 1 : 20 dilution (0.6μg) immunoprecipitating p53 in 293T whole cell lysate.

Lane 1 (input) : 293T (Human embryonic kidney epithelial cell) whole cell lysate, 10μg
Lane 2 (+) : ab33889 & 293T whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab33889 in 293T whole cell lysate.

For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889)

Predicted band size: 43 kDa

false

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • WB

Lab

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/2000 dilution

Lane 1:

A431 whole cell lysate at 10 µg

Lane 2:

A431 treated with 1μg/ml doxorubicin for 24 hours whole cell lysate at 10 µg

Lane 3:

A431 treated with 1μg/ml doxorubicin for 24 hours whole cell lysate, the membrane was incubated with alkaline phosphatase at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa

false

Exposure time: 15s

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • WB

Lab

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/1000 dilution

Lane 1:

HEK-293 (Human embryonic kidney epithelial cell) whole cell lysates at 15 µg

Lane 2:

HEK-293 (Human embryonic kidney epithelial cell) whole cell lysates, then the membrane was incubated with alkaline phosphatase at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 43 kDa

false

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • WB

Unknown

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

Lanes 1 and 5 : Extract of Hek293T incubated with etoposide (7.5 μg).
Lanes 2 and 6 : Lambda phosphatase (400 times-diluted)-treated extract of Hek293T incubated with etoposide (7.5 μg).
Lanes 3 and 7 : Lambda phosphatase (100 times-diluted)-treated extract of Hek293T incubated with etoposide (7.5 μg).
Lanes 4 and 8 : Lambda phosphatase (25 times-diluted)-treated extract of Hek293T incubated with etoposide (7.5 μg).

SDS PAGE performed under reducing conditions (100mM DTT, sample heated at 50°C).

Primary :
Lanes 1-4 : Anti p53 (phosphoS392) antibody (ab33889, unpurified) at 1/2000 dilution.
Lanes 5-8 : Anti p53 antibody (ab1101) at 1/2500 dilution.

Secondary :
Lanes 1-4 : HRP-conjugated goat anti-rabbit IgG (H&L) at 1/10000.
Lanes 5-8 : HRP-conjugated goat anti-mouse IgG (H&L) at 1/10000.

Blocked in 5% milk in PBS for 3 hours at room temperature.
Incubated with the primary antibody in 5% BSA + 50mM Tris pH 7.5 + 0.05% Tween-20 overnight at 4°C.
Incubated with the secondary antibody in blocking buffer for 2 hours at room temperature.

All lanes:

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889)

Predicted band size: 43 kDa

Observed band size: 53 kDa

true

Exposure time: 1min

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • WB

Lab

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/1000 dilution

Lane 1:

HEK-293 whole cell lysate - untreated at 10 µg

Lane 2:

HEK-293 whole cell lysate - treated with Alkaline Phosphatase at 10 µg

Secondary

All lanes:

Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 43 kDa

Observed band size: 43 kDa

false

Exposure time: 15s

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • WB

Unknown

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

All lanes:

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/500 dilution

Lane 1:

MCF7 cell lysate untreated.

Lane 2:

MCF7 cell lysate treated with 5 ug/ml Actinomycin for 3hrs.

Lane 3:

MCF7 cell lysate treated with 5 ug/ml Actinomycin for 6hrs.

Lane 4:

MCF7 cell lysate treated with 5 ug/ml Actinomycin for 18hrs.

Predicted band size: 43 kDa

Observed band size: 53 kDa

false

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • WB

Lab

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/1000 dilution

Lane 1:

RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysates at 15 µg

Lane 2:

RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysates, then the membrane was incubated with alkaline phosphatase at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 43 kDa

false

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • WB

Lab

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-p53 (phospho S392) antibody [EP155Y] (ab33889) at 1/1000 dilution

Lane 1:

PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates at 15 µg

Lane 2:

PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates, then the membrane was incubated with alkaline phosphatase. at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa

false

Dot Blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)
  • Dot

Unknown

Dot Blot - Anti-p53 (phospho S392) antibody [EP155Y] (AB33889)

Dot blot analysis of p53 (pS392) peptide (Lane 1) and p53 non-phospho peptide (Lane 2) labelling p53 (pS392) with unpurified ab33889 at a dilution of 1/1000. ab97051 (Peroxidase conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/100000.

Blocking and dilution buffer : 5% NFDM/TBST.

Exposure time : 3 minutes.

  • Carrier free

    Anti-p53 (phospho S392) antibody [EP155Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP155Y

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

Dot, WB, IHC-P, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody is specific for p53 phosphorylated on Serine 392.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/20", "IP-species-notes": "<p><strong>For unpurified use at 1/80. </strong></p>", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/250 - 1/500", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/250 - 1/500", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/250 - 1/500", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Synthetic peptide": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/1000", "Dot-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein p53 also known as TP53 or tumor protein p53 has a molecular weight of approximately 53 kDa. It acts as a transcription factor and plays a major role in cell cycle regulation apoptosis and maintaining genomic stability. This protein mainly expresses in the nucleus of cells and acts as a critical regulator of cellular responses to stress signals including DNA damage. Scientists commonly use p53 antibodies in various assays like western blot and p53 immunofluorescence to detect and study its expression and functional status in cells.
Biological function summary

P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.

Pathways

P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.

P53 mutation or inactivation is often associated with the development of cancer given its role in controlling cell division and preventing tumor formation. Specifically its dysfunction has been linked to cancers such as breast cancer and lung cancer. Additionally p53 can interact with other mutant proteins like Ras compounding mutations that contribute to tumor progression and aggressive cancer phenotypes. Understanding these interactions and the status of p53 can be important in developing targeted cancer therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 35618207, PubMed : 36634798, PubMed : 38653238, PubMed : 9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17189187, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 38653238, PubMed : 9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed : 12524540, PubMed : 17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed : 12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed : 12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed : 24051492).
See full target information TP53 phospho S392

Publications (39)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 15:23497 PubMed40603406

2025

Investigation of the mechanism of euphornin against cervical cancer using network pharmacology.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Jin,Shuhua Liu

Clinical and experimental pharmacology & physiology 52:e70022 PubMed39788129

2025

Diclofenac Enhances the Response of BRAF Inhibitor to Melanoma Through ROS/p38/p53 Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Haihong Qin,Zheng Li,Jinfeng Wu,Xiao Liu,Ruilong Wang,Jinhua Xu,Xiaohua Zhu

Frontiers in oncology 14:1433256 PubMed39717750

2024

Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11.

Applications

Unspecified application

Species

Unspecified reactive species

Vid Mlakar,Ina Oehme,Laurence Lesne,Sara Najafi,Marc Ansari,Fabienne Gumy-Pause

Biomedical optics express 15:4081-4100 PubMed39022556

2024

Long-term ultraviolet B irradiation at 297 nm with light-emitting diode improves bone health via vitamin D regulation.

Applications

Unspecified application

Species

Unspecified reactive species

Wenwen Liu,Ying Wang,Haixia Qiu,Defu Chen,Shengnan Wu,Quanbo Ji,Biao Chang,Yunqi Li,Hongyou Zhao,Yizhou Tan,Ying Gu

Heliyon 10:e28364 PubMed38596137

2024

Plumbagin induces ferroptosis in colon cancer cells by regulating p53-related SLC7A11 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Bingyi Wang,Weiqi Kong,Lixin Lv,Zhiqiang Wang

Experimental dermatology 33:e15006 PubMed38284200

2024

Q-switched 1064 nm Nd: YAG laser restores skin photoageing by activating autophagy by TGFβ1 and ITGB1.

Applications

Unspecified application

Species

Unspecified reactive species

Huiyi Xiang,Xiaorong Jia,Xiaoxia Duan,Qi Xu,Ruiqi Zhang,Yunting He,Zhi Yang

Biology of the cell 116:e202300042 PubMed37919852

2023

Liproxstatin-1 alleviates cartilage degradation by inhibiting chondrocyte ferroptosis in the temporomandibular joint.

Applications

Unspecified application

Species

Unspecified reactive species

Bei Cheng,Jun Zhang,Qinhao Shen,Zheyi Sun,Yingwei Luo,Yu Hu

Cancer biology & therapy 24:2223377 PubMed37370246

2023

LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.

Applications

Unspecified application

Species

Unspecified reactive species

Huiyong Chen,Linhui Wang,Jingting Liu,Zihao Wan,Lin Zhou,Hongliang Liao,Renping Wan

Nature communications 14:505 PubMed36720864

2023

Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Yunzhi Wang,Rongkui Luo,Xuan Zhang,Hang Xiang,Bing Yang,Jinwen Feng,Mengjie Deng,Peng Ran,Akesu Sujie,Fan Zhang,Jiajun Zhu,Subei Tan,Tao Xie,Pin Chen,Zixiang Yu,Yan Li,Dongxian Jiang,Xiaobiao Zhang,Jian-Yuan Zhao,Yingyong Hou,Chen Ding

Naunyn-Schmiedeberg's archives of pharmacology 396:365-374 PubMed36374307

2022

Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jinfeng Liu,Chang Zhang,Shuang Liu,Xiaokang Wang,Xiongzhi Wu,Jian Hao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com